The home sequential compression devices market in Europe is expected to grow from US$ 262.91 million in 2021 to US$ 405.94 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.
Venous insufficiency disorders can be treated by procedures such as compression stockings and wraps, venopneumatic compression pumps, minimally invasive venous ablation, and radiofrequency ablation.Sequential compression devices operate through automatic and sequential expansion and collapse to drive fluids back into the veins as well as to push these fluids back to heart from the lower parts of the body.
The sequential compression pumps are widely used in hospitals, clinics, and home care settings.Patients need to place their affected legs in unique sleeves connected to a portable pump.
These sleeves consist of built-in chambers that fill with air and then deflate sequentially to push fluids toward desired directions.Thus, these devices are simple to use; healthcare providers educate the patients about the use of home sequential compression devices.
Moreover, owing to the ongoing COVID-19 pandemic, patients prefer taking medical treatments at home to avoid the risk of COVID-19 infection. The awareness about health insurance coverage for venous insufficiency treatments by different health insurance schemes further fuels the home sequential compression devices market growth. For instance, the UnitedHealthcare Medicare, one of the leading insurance providers in the US, offers coverage for the at-home use of pneumatic compression devices to treat lymphedema. Additionally, various rental services for medical devices are being used in home care settings, which is expected to fuel the demand for home sequential compression devices system in Europe.
Based on type, the standard segment led the Europe home sequential compression devices system market in 2021.A standard sequential compression system (the SCD Express) can detect the individual refill time of the two lower limbs separately.
Patients continue to have poor outcomes after suffering blood clots in the legs or arms, despite physician orders for therapy with normal therapy, then HCPs suggest patients standard sequential compression devices.Standard sequential compression devices can apply pressure from the calf to the thigh region.
Squeezing the blood from the limb and shifting it proximally is how standard devices function.This helps to increase venous blood flow velocity in the lower limbs, which decreases venous stasis.
The devices also stimulate the release of anti-thrombotic factors, which inhibit activated factor VII, and nitric oxide from the vascular endothelium. The ACCP guidelines suggest that the device must be used for at least 18 hours a day. Patients may only use standard SCDs if they stay in bed and are linked to an external power source.
The European economy is severely affected due to the exponential growth of COVID-19 cases in the region.Spain, Italy, Germany, France, and the UK are among the most affected European countries.
As per the Worldometer, as of July 1st, 2021, Spain, the UK, Italy, Germany, and France recorded 3,808,960; 4,800,907; 4,259,909; 3,736,223; and 5,775,301, respectively.Resulting from these situations, the regional government has announced the local restrictions in countries and ordered them to follow the lockdown rules.
However, the demand for home medical devices has been increasing as there is fear of COVID-19 infection outside.The COVID-19 pandemic has resulted in diversion of healthcare resources including workforce, critical supplies, emergency, and intensive care unit (ICU) facilities to the management of patients infected with SARS-CoV-2 virus.
Elective interventions and surgical procedures in most European countries have been postponed and operating room resources have been diverted to manage the pandemic. Limitations on direct personal contact and physical (social) distancing have influenced access to care. Patients with venous and lymphatic disorders or vascular anomalies continue to need expert care within current public health constraints. In addition, there is growing evidence that COVID-19 may predispose patients to both arterial and venous thromboembolic (VTE) disease and extensive coagulopathies further complicating the prognosis of the affected patients. To facilitate triage in this situation European Venous Forum (EVF) and European College of Phlebology (ECoP) in collaboration with various international organizations has developed Venous and Lymphatic Triage and Acuity Scale (VELTAS) to rationalize and harmonize the management of these patients during this difficult period. Such a factors will support home sequential compression device adoption and will have positive impact on market.
The overall Europe home sequential compression devices system market size has been derived using both primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market.
The process also serves the purpose of obtaining an overview and forecast for the Europe home sequential compression devices system market with respect to all the segments pertaining to the region.Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic.
The participants who typically take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants, such as valuation experts, research analysts, and key opinion leaders specializing in the Europe. AIROS Medical; Arjo Medical Devices; Breg Inc.; Cardinal Health Inc; DJO Global, Inc.; DSMAREF CO.LTD; and Mego Afek ltd.are among the key players operating in the Europe home sequential compression devices system market.
Our reports have been used by over 10K customers, including:
The Global Heparin Market size is expected to reach $10 billion by 2027, rising at a market growth of 6.5% CAGR during the forecast period. Heparin is also called unfractionated heparin (UFH). It refers to a glycosaminoglycan that naturally forms in the body. Heparin is widely used as an anticoagulant in medicine that acts as a blood thinner....
KEY FINDINGS The global ECG equipment market is projected to register a CAGR of 5.57% during the forecast period, 2021-2028. The favorable regulations, increasing healthcare expenditure, growing usage of monitoring devices, and rising cardiovascular disease drive market growth. MARKET INSIGHTS ECG...
The personal mobility devices market is expected to register a CAGR of nearly 5.85%, with a revenue of approximately USD 8,163.99 million in 2020, and it is expected to reach USD 11,527.84 million by 2026. Many people with chronic conditions or people with physical disabilities are not able to follow the guidelines and procedures to...
The health economics and outcomes research (HEOR) services market in South and Central America is projected to reach US$ 89.1 million by 2027 from US$ 49.2 million in 2020; it is estimated to grow at a CAGR of 8.8% from 2020 to 2027. The healthcare industry has significantly evolved since there is an integration of information technology,...
The micro catheters and micro guidewires market in North America is expected to grow from US$ 605.47 million in 2021 to US$ 895.74 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028. Surging incidence of neurovascular diseases is also bolstering the growth of the industry.The neurovascular system is highly...
The global amniotic products market is projected to reach USD 1.0 billion by 2026 from USD 0.7 billion in 2021, at a CAGR of 8.2% during the forecast period. The growth in this market can be attributed to the growth in the target patient population, rising incidence of burn injuries, awareness programs for wound care treatment and management,...
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
The global urinalysis market size is projected to reach USD 4.9billion by 2026 from USD 3.5billion in 2021, at a CAGR of 7.2% during the forecast period. Market growth is driven by factors such as increasing burden of UTIs, diabetes, and kidney & liver diseases, rising geriatric population and the subsequent increase in age- associated diseases...
344 pages •
By The Business Research Company
• Sep 2021
Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global anti-asthmatics and COPD drugs market as it emerges from the COVID 19 shut down. Description: Where...
The global revenue cycle management market is projected to reach USD 67.8 billion by 2026 from USD 40.9 billion in 2021, at a CAGR of 10.6% during the forecast period. The growth of this market is majorly attributed to the growing regulatory requirements & government initiatives to boost the adoption of RCM solutions, increasing patient volumes,...
Outpatient Facility Number
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.